Private Label CLA Complex 1155mg

Conjugated linoleic acid is a family of linoleic-acid isomers with conjugated double bonds, with cis-9, trans-11 and trans-10, cis-12 among the most studied biologically active isomers. Experimental research links CLA to PPAR-regulated gene expression, eicosanoid metabolism, fatty-acid oxidation, lipogenesis, and adipocyte differentiation, while human body-composition results are less consistent than animal findings. A strong CLA product therefore depends on defined total CLA content, characterized isomer composition, and oxidation control rather than broad outcome promises.

To ensure that Cpack Manufacturing is providing a consistent CLA Complex 1155mg softgel, the lipid-based fill is handled through controlled softgel processing designed for uniform fill weight and protection from unnecessary oxidation. The 1,155 mg complex gives brands a clearly specified fatty-acid dose in a familiar sports-nutrition format.

The main benefits provided by our Private Label CLA Complex 1155mg supplements are as follows:

• CLA Complex 1,155 mg — A defined 1,155 mg conjugated linoleic acid complex composed of positional and geometric isomers of linoleic acid.
• Cis-9, Trans-11 CLA — One of the two most studied biologically active CLA isomers, with metabolic behavior that differs from the trans-10, cis-12 isomer.
• Trans-10, Cis-12 CLA — A CLA isomer investigated for effects on adipocyte differentiation, lipogenesis, lipolysis, and fatty-acid oxidation pathways.
• PPAR Signaling — CLA and its metabolites can interact with peroxisome proliferator-activated receptor pathways that regulate lipid-metabolism gene expression.
• Eicosanoid Metabolism — Experimental research indicates CLA can influence formation of lipid-derived signaling mediators, providing a second mechanistic route distinct from PPAR activity.